Advertisement
Screener

Indivior Pharmaceuticals, Inc. (SUPN) Subsidiaries

Indivior Pharmaceuticals, Inc. Subsidiaries

Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (8 lists). Names and jurisdictions are as filed.

  • 2026-03-02: Subsidiary Name of Subsidiaries; Jurisdiction Jurisdiction of Organization.
  • 2026-03-02: Subsidiary Sage Therapeutics, LLC; Jurisdiction Delaware.
  • 2026-03-02: Subsidiary Sage Securities Corporation; Jurisdiction Massachusetts.
  • 2026-03-02: Subsidiary MDD US Enterprises, LLC; Jurisdiction Delaware.
Annual report filedSubsidiaryJurisdiction
2026-03-02Name of SubsidiariesJurisdiction of Organization
2026-03-02Sage Therapeutics, LLCDelaware
2026-03-02Sage Securities CorporationMassachusetts
2026-03-02MDD US Enterprises, LLCDelaware
2026-03-02MDD US Operations, LLCDelaware
2026-03-02Adamas Pharmaceuticals, LLCDelaware
2026-03-02Adamas Operations, LLCDelaware
2026-03-02Adamas Holdings, LLCDelaware
2026-03-02Biscayne Neurotherapeutics, Inc.Delaware
2025-02-25Name of SubsidiariesJurisdiction of Organization
2025-02-25MDD US Enterprises, LLCDelaware
2025-02-25MDD US Operations, LLCDelaware
2025-02-25Supernus Europe Ltd.United Kingdom
2025-02-25Adamas Pharmaceuticals, LLCDelaware
2025-02-25Adamas Operations, LLCDelaware
2025-02-25Adamas Holdings, LLCDelaware
2025-02-25Biscayne Neurotherapeutics, Inc.Delaware
2024-02-27Name of SubsidiariesJurisdiction of Organization
2024-02-27MDD US Enterprises, LLCDelaware
2024-02-27MDD US Operations, LLCDelaware
2024-02-27Supernus Europe Ltd.United Kingdom
2024-02-27Adamas Pharmaceuticals, LLCDelaware
2024-02-27Adamas Operations, LLCDelaware
2024-02-27Adamas Holdings, LLCDelaware
2024-02-27Biscayne Neurotherapeutics, Inc.Delaware
2023-03-09Name of SubsidiariesJurisdiction of Organization
2023-03-09MDD US Enterprises, LLCDelaware
2023-03-09MDD US Operations, LLCDelaware
2023-03-09Supernus Europe Ltd.United Kingdom
2023-03-09Adamas Pharmaceuticals, LLCDelaware
2023-03-09Adamas Operations, LLCDelaware
2023-03-09Adamas Holdings, LLCDelaware
2023-03-09Biscayne Neurotherapeutics, Inc.Delaware
2022-04-13Name of SubsidiariesJurisdiction of Organization
2022-04-13MDD US Enterprises, LLCDelaware
2022-04-13MDD US Operations, LLCDelaware
2022-04-13Supernus Europe Ltd.United Kingdom
2022-04-13Adamas Pharmaceuticals, Inc.Delaware
2022-04-13Adamas Operations, LLCDelaware
2022-04-13Adamas Holdings, LLCDelaware
2022-04-13Biscayne Neurotherapeutics, Inc.Delaware
2021-03-08Name of SubsidiariesJurisdiction of Organization
2021-03-08MDD US Enterprises, LLCDelaware
2021-03-08MDD US Operations, LLCDelaware
2021-03-08Supernus Europe Ltd.United Kingdom
2021-03-08Biscayne Neurotherapeutics, Inc.Delaware
2020-02-28Name of SubsidiariesJurisdiction of Organization
2020-02-28Supernus Europe Ltd.United Kingdom
2020-02-28Biscayne Neurotherapeutics, Inc.Delaware
2020-02-28Biscayne Neurotherapeutics Australia Pty Ltd.Australia
2019-03-01Name of SubsidiariesJurisdiction of Organization
2019-03-01Supernus Europe Ltd.United Kingdom
2019-03-01Biscayne Neurotherapeutics, Inc.Delaware
2019-03-01Biscayne Neurotherapeutics Australia Pty Ltd.Australia

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38